Oral GLP-1s (Rybelsus and Beyond) Until recently, Rybelsus (manufactured by Novo Nordisk) was the only oral medication in its class with FDA approval
The American Diabetes Association (ADA) 2026 guidelines recommend semaglutide in patients with advanced CKD without specifying eGFR cutoffs and note that its glucose-lowering effect is preserved at low eGFR levels, in contrast to SGLT2 inhibitors, whose glycemic efficacy diminishes with declining kidney function ( In our cohort, semaglutide use was associated with a modest reduction in HbA1c (0.31 2.57%, p = 0.630) and a numerically large but statistically non-significant reduction in body weight (12.63 24.03 kg, p = 0.074)
By mimicking both of these hormones, tirzepatide provides a two-pronged approach to managing hunger and metabolism
This type of gut microbiome test will also test for specific pathogens, but it goes a step further
Oral tirzepatide and oral semaglutide drops provide needle-free options that some users prefer
190 Initially, GLP-1 secretion by L-cells was believed to occur in a glucose-dependent manner